ARGNF:OTCMKTS
argenx SE
790,15 USD
0,00%
(0,00) 1D
13-окт., 10:39:58 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
51,65 млд
Avg. vol.
14,00
Volume
0,00
52-wk high
1 020,00 USD
52-wk low
708,72 USD
Beta
0,46
Shares outstanding
62,89 млн
No. of employees
2 миң
Mkt. cap
51,65 млд
Avg. vol.
14,00
Volume
0,00
52-wk high
1 020,00 USD
52-wk low
708,72 USD
Beta
0,46
Shares outstanding
62,89 млн
No. of employees
2 миң
News stories
From web sources and news partners
Yahoo Finance
·
3 саат мурун
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
ad-hoc-news.de
·
9 саат мурун
argenx schedules third-quarter results for October 22: stock pre-market at EUR 756.30
Investing.com South Africa
·
1 күн мурун
Argenx shares may move 5.5% on earnings release next week By Investing.com
TipRanks
·
1 күн мурун
argenx Schedules Q3 2026 Results Call and Business Update
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE